Back to PO PointState Capital LP

TEVA

Showing 8 of 10 quarters

Position history for POPointState Capital LP's holdings in Teva Pharmaceutical Industries Limited

No. PointState Capital exited its TEVA (Teva Pharmaceutical Industries) position in Q2 2026. Its Q1 2026 13F listed 1,973,782 shares worth $59.5M. PointState Capital first reported TEVA in Q1 2024 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$175.8M

Total Shares Change

-9.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$33.88
0
2026-Q1
Decreased
2M
-48.0%
$59.5M0.8%$30.12
0
2025-Q4
Decreased
3.8M
-81.7%
$118.4M1.7%$31.21
0
2025-Q3
Unchanged
20.7M
0.0%
$418.4M6.2%$20.20
0
2025-Q2
Increased
20.7M
+36.9%
$347.1M5.3%$16.76
80
2025-Q1
Increased
15.1M
+11.9%
$232.6M3.4%$15.37
64
2024-Q4
Increased
13.5M
+38.6%
$298.1M5.4%$22.04
80
2024-Q3
Increased
9.8M
+6.7%
$175.8M3.2%$18.02
61

Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors

Optional analytics helps us improve. How it’s used